ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,432Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 300

$923K Total Retail Price of All Prescriptions

Rank: 12 out of 300

537 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 537 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 537 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 13,807 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $81 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
PRAVASTATIN SODIUM 1,015 936 1 15
AMLODIPINE BESYLATE 615 514 2 2
LEVOTHYROXINE SODIUM 529 466 3 9
FUROSEMIDE 486 411 4 3
LISINOPRIL 484 428 5 4
LOSARTAN POTASSIUM 369 327 6 29
METOPROLOL SUCCINATE 360 323 7 6
WARFARIN SODIUM 353 317 8 10
OMEPRAZOLE 350 253 9 11
POTASSIUM CHLORIDE 335 263 10 22
GABAPENTIN 282 236 11 7
TRAMADOL HCL 268 197 12 23
CLOPIDOGREL 246 223 13 18
ZETIA 239 214 14 109
MELOXICAM 238 181 15 27
METFORMIN HCL ER 235 172 16 131
SERTRALINE HCL 232 218 17 41
METOPROLOL TARTRATE 218 180 18 13
PLAVIX 199 183 19 24
JANUVIA 198 175 20 100
HYDROCHLOROTHIAZIDE 196 192 21 20
METFORMIN HCL 176 137 22 19
GLIMEPIRIDE 174 111 23 51
NAMENDA 172 165 24 48
ATORVASTATIN CALCIUM 169 146 25 14
BYSTOLIC 160 128 26 59
FAMOTIDINE 155 151 27 192
ALLOPURINOL 147 139 28 44
DIGOXIN 147 144 28 39
RAMIPRIL 136 111 30 63
DONEPEZIL HCL 131 131 31 57
NIFEDIPINE ER 129 115 32 120
AMOX TR-POTASSIUM CLAVULANATE 127 98 33 223
TAMSULOSIN HCL 126 121 34 8
ESCITALOPRAM OXALATE 126 116 34 78
FLUTICASONE PROPIONATE 125 106 36 34
PREDNISONE 125 103 36 33
BENICAR 124 111 38 191
CARVEDILOL 123 113 39 12
LOVAZA 120 101 40 129
NEXIUM 118 101 41 17
ONGLYZA 112 68 42 231
METHYLPREDNISOLONE 110 89 43 179
CRESTOR 107 103 44 26
ALENDRONATE SODIUM 98 80 45 61
CYMBALTA 96 57 46 37
HYDRALAZINE HCL 88 87 47 56
CYCLOBENZAPRINE HCL 87 59 R 48 71
LANTUS 86 48 49 125
CLONIDINE HCL 83 69 50 50
HYDROCODONE-ACETAMINOPHEN 83 54 S3 50 1
FINASTERIDE 81 69 52 24
ATENOLOL 78 73 53 31
RANITIDINE HCL 78 61 53 112
QUETIAPINE FUMARATE 76 72 55 79
AZITHROMYCIN 73 57 56 72
SPIRONOLACTONE 73 63 56 92
ISOSORBIDE MONONITRATE ER 70 66 58 32
SINGULAIR 68 59 59 114
KLOR-CON M20 68 64 59 89
CIPROFLOXACIN HCL 67 59 61 28
PANTOPRAZOLE SODIUM 66 55 62 35
CITALOPRAM HBR 65 55 63 54
BUPROPION HCL SR 62 50 64 339
TRICOR 62 46 64 161
RIVASTIGMINE 61 61 66 283
LIPITOR 60 50 67 115
TRILIPIX 60 46 67 253
TRAZODONE HCL 59 20 69 65
DOXAZOSIN MESYLATE 57 57 70 90
TRAMADOL HCL-ACETAMINOPHEN 56 29 71 167
WELCHOL 50 44 72 339
EXELON 50 50 72 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.